Morgan Stanley Catalent, Inc. Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Catalent, Inc. stock. As of the latest transaction made, Morgan Stanley holds 1,447,614 shares of CTLT stock, worth $91.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,447,614

Previous 1,224,988 18.17%

Holding current value

$91.9 Million

Previous $68.9 Million 27.29%

% of portfolio

0.01%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$56.16 - $60.96 $12.5 Million - $13.6 Million	222,626 Added 18.17%	1,447,614 $87.7 Million
Q2 2024 Oct 17, 2024	SELL	$53.58 - $57.02 $11.1 Million - $11.8 Million	-206,375 Reduced 14.42%	1,224,988 $68.9 Million
Q2 2024 Aug 14, 2024	SELL	$53.58 - $57.02 $11.1 Million - $11.8 Million	-206,375 Reduced 14.42%	1,224,988 $68.9 Million
Q1 2024 Oct 17, 2024	BUY	$42.56 - $59.82 $8.78 Million - $12.3 Million	206,375 Added 16.85%	1,431,363 $80.8 Million
Q1 2024 Aug 16, 2024	SELL	$42.56 - $59.82 $9.99 Million - $14 Million	-234,746 Reduced 14.09%	1,431,363 $80.8 Million
Q1 2024 May 15, 2024	SELL	$42.56 - $59.82 $9.99 Million - $14 Million	-234,746 Reduced 14.09%	1,431,363 $80.8 Million
Q4 2023 Aug 16, 2024	BUY	$32.18 - $46.57 $14.2 Million - $20.5 Million	441,121 Added 36.01%	1,666,109 $74.9 Million
Q4 2023 Feb 13, 2024	SELL	$32.18 - $46.57 $18.3 Million - $26.4 Million	-567,185 Reduced 25.4%	1,666,109 $74.9 Million
Q3 2023 Nov 15, 2023	SELL	$44.2 - $50.2 $18.4 Million - $20.9 Million	-416,617 Reduced 15.72%	2,233,294 $102 Million
Q2 2023 Aug 14, 2023	BUY	$31.86 - $67.26 $1.87 Million - $3.96 Million	58,841 Added 2.27%	2,649,911 $115 Million
Q1 2023 May 15, 2023	BUY	$45.44 - $74.26 $7.62 Million - $12.4 Million	167,635 Added 6.92%	2,591,070 $170 Million
Q4 2022 Feb 14, 2023	BUY	$41.39 - $81.0 $53.3 Million - $104 Million	1,287,018 Added 113.25%	2,423,435 $109 Million
Q3 2022 Nov 14, 2022	SELL	$72.36 - $113.1 $8.65 Million - $13.5 Million	-119,478 Reduced 9.51%	1,136,417 $82.2 Million
Q2 2022 Oct 27, 2022	BUY	$87.2 - $114.05 $76.5 Million - $100 Million	877,133 Added 231.58%	1,255,895 $135 Million
Q2 2022 Aug 15, 2022	BUY	$87.2 - $114.05 $76.5 Million - $100 Million	877,133 Added 231.58%	1,255,895 $135 Million
Q1 2022 Oct 27, 2022	SELL	$94.19 - $124.49 $82.6 Million - $109 Million	-877,133 Reduced 69.84%	378,762 $42 Million
Q1 2022 May 13, 2022	SELL	$94.19 - $124.49 $5.69 Million - $7.52 Million	-60,384 Reduced 13.75%	378,762 $42 Million
Q4 2021 Feb 14, 2022	SELL	$119.57 - $139.07 $11.6 Million - $13.4 Million	-96,647 Reduced 18.04%	439,146 $56.2 Million
Q3 2021 Nov 15, 2021	BUY	$109.17 - $142.35 $58.5 Million - $76.3 Million	535,793 New	535,793 $71.3 Million

Others Institutions Holding CTLT

# of Institutions

515

Shares Held

149M

Call Options Held

575K

Put Options Held

2.03M

View Full List

About Catalent, Inc.

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

More about CTLT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account